TNNI3 and breast cancer: Another study evaluated 95 patients with breast cancer receiving trastuzumab after chemotherapy with AC, and showed that an increase in cTnI at 14 weeks after the beginning of chemotherapy preceded the maximum deterioration of the LVEF, but did not predict or relate to the maximum decline in the LVEF [45].